Cardlytics Net Invested Capital from 2010 to 2024
CDLX Stock | USD 11.94 0.24 1.97% |
Net Invested Capital | First Reported 2010-12-31 | Previous Quarter 392.4 M | Current Value 334.2 M | Quarterly Volatility 318.1 M |
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.21 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
Cardlytics | Net Invested Capital |
Latest Cardlytics' Net Invested Capital Growth Pattern
Below is the plot of the Net Invested Capital of Cardlytics over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Cardlytics' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital | 10 Years Trend |
|
Net Invested Capital |
Timeline |
Cardlytics Net Invested Capital Regression Statistics
Arithmetic Mean | 93,216,647 | |
Geometric Mean | 209,602,920 | |
Coefficient Of Variation | 341.28 | |
Mean Deviation | 261,324,423 | |
Median | (151,775,000) | |
Standard Deviation | 318,126,892 | |
Sample Variance | 101204.7T | |
Range | 1B | |
R-Value | 0.80 | |
Mean Square Error | 38566.9T | |
R-Squared | 0.65 | |
Significance | 0.0003 | |
Slope | 57,180,692 | |
Total Sum of Squares | 1416866.1T |
Cardlytics Net Invested Capital History
About Cardlytics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cardlytics income statement, its balance sheet, and the statement of cash flows. Cardlytics investors use historical funamental indicators, such as Cardlytics's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Cardlytics investors may use each financial statement separately, they are all related. The changes in Cardlytics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cardlytics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cardlytics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Invested Capital | 392.4 M | 334.2 M |
Pair Trading with Cardlytics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardlytics Stock
0.67 | SE | Sea Financial Report 21st of May 2024 | PairCorr |
Moving against Cardlytics Stock
0.83 | UONEK | Urban One Class Report 4th of July 2024 | PairCorr |
0.81 | LPTV | Loop Media Financial Report 9th of May 2024 | PairCorr |
0.78 | EVC | Entravision Communications Financial Report 2nd of May 2024 | PairCorr |
0.77 | WMG | Warner Music Group Financial Report 14th of May 2024 | PairCorr |
0.74 | IAS | Integral Ad Science Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cardlytics Correlation against competitors. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (3.69) | Revenue Per Share 8.474 | Quarterly Revenue Growth 0.081 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.